As of 2024-07-27, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (149.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.32 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -1418.4%.
The range of the Relative Valuation is (151.41) - (147.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 31.4x - 38.2x | 31.8x |
Forward P/E multiples | 27.6x - 30.5x | 30.1x |
Fair Price | (151.41) - (147.27) | (149.24) |
Upside | -1437.6% - -1400.9% | -1418.4% |
Date | P/E |
2024-07-26 | -2.35 |
2024-07-25 | -2.27 |
2024-07-24 | -2.25 |
2024-07-23 | -2.32 |
2024-07-22 | -2.19 |
2024-07-19 | -2.09 |
2024-07-18 | -2.15 |
2024-07-17 | -2.30 |
2024-07-16 | -2.31 |
2024-07-15 | -2.29 |
2024-07-12 | -2.35 |
2024-07-11 | -2.29 |
2024-07-10 | -1.92 |
2024-07-09 | -1.90 |
2024-07-08 | -1.80 |
2024-07-05 | -1.85 |
2024-07-03 | -1.73 |
2024-07-02 | -1.75 |
2024-07-01 | -1.79 |
2024-06-28 | -1.68 |
2024-06-27 | -1.61 |
2024-06-26 | -1.62 |
2024-06-25 | -1.59 |
2024-06-24 | -1.65 |
2024-06-21 | -1.68 |
2024-06-20 | -1.67 |
2024-06-18 | -1.78 |
2024-06-17 | -1.85 |
2024-06-14 | -1.89 |
2024-06-13 | -1.96 |
2024-06-12 | -1.97 |
2024-06-11 | -2.01 |
2024-06-10 | -2.02 |
2024-06-07 | -1.99 |
2024-06-06 | -2.08 |
2024-06-05 | -2.10 |
2024-06-04 | -2.09 |
2024-06-03 | -2.11 |
2024-05-31 | -2.10 |
2024-05-30 | -2.03 |
2024-05-29 | -2.08 |
2024-05-28 | -2.15 |
2024-05-24 | -2.28 |
2024-05-23 | -2.27 |
2024-05-22 | -2.33 |
2024-05-21 | -2.28 |
2024-05-20 | -2.30 |
2024-05-17 | -2.49 |
2024-05-16 | -2.65 |
2024-05-15 | -2.71 |